„Glycated Haemogloin, Fasting Plasma Glucose, Plasminogen Activator Inhibitor Type-1, and Soluble Thrombomodulin Levels in Patients with Type 2 Diabetes Mellitus”, NJPS, köt. 36, sz. 2, o. 159–164, dec. 2021, doi: 10.54548/njps.v36i2.3.